These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 10630025)
1. [Does orlistat really offer help for the treatment of obesity?]. Orozco P Aten Primaria; 1999 Nov; 24(8):445-6. PubMed ID: 10630025 [No Abstract] [Full Text] [Related]
2. More about orlistat. Lucas KH; Kaplan-Machlis B Pharmacotherapy; 2000 Jul; 20(7):872-3. PubMed ID: 10907983 [No Abstract] [Full Text] [Related]
3. Orlistat half the dose without a prescription: new status. In excess body weight: often uncomfortable and don't expect miracles. Frequent gastrointestinal disturbances for a weight loss of a few kilos. Better to encourage dietary measures, exercise and individualised support. Prescrire Int; 2009 Jun; 18(101):101. PubMed ID: 19637413 [No Abstract] [Full Text] [Related]
4. Orlistat, a gastrointestinal lipase inhibitor, in therapy of obesity with concomitant hyperlipidemia. Micić D; Ivković-Lazar T; Dragojević R; Jorga J; Stokić E; Hajduković Z Med Pregl; 1999; 52(9-10):323-33. PubMed ID: 10624380 [TBL] [Abstract][Full Text] [Related]
5. Orlistat for obesity. Med Lett Drugs Ther; 1999 Jun; 41(1055):55-6. PubMed ID: 10436767 [No Abstract] [Full Text] [Related]
6. Obesity drug endorsed by NICE. Wise J BMJ; 2001 Mar; 322(7287):637. PubMed ID: 11250844 [No Abstract] [Full Text] [Related]
7. Orlistat and obesity: be aware of lichenoid drug eruption. Koca Kalkan I; Kalpaklioglu AF; Atasoy P; Karabulut AA Eur J Dermatol; 2011; 21(3):456-7. PubMed ID: 21680292 [No Abstract] [Full Text] [Related]
8. Is blockade of pancreatic lipase the answer? Halsted CH Am J Clin Nutr; 1999 Jun; 69(6):1059-60. PubMed ID: 10357720 [No Abstract] [Full Text] [Related]
9. [Fat-normalizing nutrition. Therewith your patients escape from the yo-yo effect]. MMW Fortschr Med; 2003 Mar; 145(13):58. PubMed ID: 15101543 [No Abstract] [Full Text] [Related]
10. Obesity: can a new drug help? Harv Mens Health Watch; 1999 Oct; 4(3):6-8. PubMed ID: 10529295 [No Abstract] [Full Text] [Related]
12. Pancreatitis associated with the use of sitagliptin and orlistat combination: a case report. Garg R; Hussey C; Ibrahim S Diabet Med; 2010 Apr; 27(4):485-6. PubMed ID: 20536524 [No Abstract] [Full Text] [Related]
13. What is the long-term efficacy and tolerability of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity in primary care? Leiser JP; Gunning K J Fam Pract; 2000 Jun; 49(6):572-3. PubMed ID: 10923560 [No Abstract] [Full Text] [Related]
14. Lipid metabolic enzymes: emerging drug targets for the treatment of obesity. Shi Y; Burn P Nat Rev Drug Discov; 2004 Aug; 3(8):695-710. PubMed ID: 15286736 [No Abstract] [Full Text] [Related]
16. [Comment of J. Fritze: Is therapy of obesity with orlistat medically necessary?]. Wirth A Versicherungsmedizin; 1999 Sep; 51(3):137-8; author reply 138-9. PubMed ID: 10516837 [No Abstract] [Full Text] [Related]
17. Outdated and misleading review of orlistat. Van R; Walt L Can Fam Physician; 1999 Dec; 45():2849-50, 2852. PubMed ID: 10626048 [No Abstract] [Full Text] [Related]
18. Effectiveness of orlistat versus diet and exercise for weight gain associated with antidepressant use: a pilot study. Schwartz TL; Jindal S; Simionescu M; Nihalani N; Azhar N; Tirmazi S; Hussein J J Clin Psychopharmacol; 2004 Oct; 24(5):555-6. PubMed ID: 15349017 [No Abstract] [Full Text] [Related]
19. Orlistat: its current status as an anti-obesity drug. Ballinger A; Peikin SR Eur J Pharmacol; 2002 Apr; 440(2-3):109-17. PubMed ID: 12007529 [TBL] [Abstract][Full Text] [Related]